Home > Boards > US Listed > Medical - Drugs > TG Therapeutics, Inc. (TGTX)

SYMBOL CHANGES

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Cakeman28 Member Profile
 
Followed By 7
Posts 526
Boards Moderated 0
Alias Born 02/24/11
160x600 placeholder
TG Therapeutics completes rolling submission of ublituximab combo BLA as leukemia treatment Seeking Alpha - 3/29/2021 8:03:48 AM
TG Therapeutics Completes Rolling Submission of Biologics License Application to the U.S. Food and Drug Administration for Ub... GlobeNewswire Inc. - 3/29/2021 7:42:09 AM
TG Therapeutics Announces Publication of Results from the UNITY-NHL Phase 2b Trial Evaluating Umbralisib Monotherapy in Patie... GlobeNewswire Inc. - 3/9/2021 7:30:00 AM
TG Therapeutics to Present Results from the ULTIMATE I & II Phase 3 Trials Evaluating Ublituximab in Multiple Sclerosis at th... GlobeNewswire Inc. - 3/4/2021 4:30:00 PM
TG Therapeutics to Present at the H.C. Wainwright Global Life Sciences Conference GlobeNewswire Inc. - 3/4/2021 7:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/2/2021 7:08:11 AM
TG Therapeutics EPS misses by $0.13, beats on revenue Seeking Alpha - 3/2/2021 7:06:25 AM
TG Therapeutics Provides Business Update and Reports Fourth Quarter and Year-End 2020 Financial Results GlobeNewswire Inc. - 3/2/2021 7:00:00 AM
Annual Report (10-k) Edgar (US Regulatory) - 3/1/2021 4:03:44 PM
TG Therapeutics to Host Conference Call on Fourth Quarter and Year-End 2020 Financial Results and Business Update GlobeNewswire Inc. - 2/26/2021 7:30:00 AM
TG Therapeutics reports final data from ublituximab combo in blood cancer Seeking Alpha - 2/23/2021 8:10:40 AM
TG Therapeutics Announces Publication of Final Results from the Phase 3 GENUINE Trial Evaluating Ublituximab Plus Ibrutinib i... GlobeNewswire Inc. - 2/23/2021 7:30:00 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/16/2021 4:38:26 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/10/2021 4:50:37 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/10/2021 4:35:44 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 2/10/2021 12:08:23 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/8/2021 10:35:49 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/8/2021 7:02:02 AM
TG’s Ukoniq Gets FDA Nod For Lymphoma Therapies; Shares Pop 12% TipRanks - 2/7/2021 8:34:17 AM
TG Therapeutics Announces FDA Accelerated Approval of UKONIQ™ (umbralisib) GlobeNewswire Inc. - 2/5/2021 1:54:45 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/1/2021 8:35:06 AM
TG Therapeutics to Participate in the B. Riley Securities Oncology Investor Conference GlobeNewswire Inc. - 1/15/2021 7:00:00 AM
TG Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference GlobeNewswire Inc. - 1/8/2021 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/4/2021 4:31:06 PM
Annual Statement of Changes in Beneficial Ownership (5) Edgar (US Regulatory) - 12/31/2020 4:31:25 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences